Vertex Pharmaceuticals Incorporated - Common Stock — Quarterly Financial Statistics (NASDAQ:VRTX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 818.9 M1.07 B1.24 B498 M1.43 B 4.24 B Cash from investing activities -55.8 M-484.5 M-117 M-288.1 M-431.9 M -1.32 B Cash from financing activities -680.4 M-349.2 M-1.15 B-77.2 M-538.8 M -2.12 B Free cash flow 818.9 M1.07 B1.24 B498 M1.43 B 4.24 B

News

Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors

What to Expect From Vertex Pharmaceuticals' Next Quarterly Earnings Report

S&P 500 Top Stock Gainers Today, 7/10/26 - TipRanks.com

Stock Market Mixed As Oil Prices Jump; Delta Air, SK Hynix In Focus: Weekly Review

If You Invested $1000 in Vertex Pharmaceuticals a Decade Ago, This is How Much It'd Be Worth Now

3 Trending Stocks to Watch, According to Analysts – 7/9/2026 - TipRanks.com

Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note

Andrew Hill Investment Advisors' Q2 2026 Significant Positions

VRTX to Strengthen Rare Disease Portfolio With $10B Crinetics Buyout

Why Is Crinetics Stock (CRNX) Surging Nearly 100% in Pre-Market Today, 7/7/26? Analysts React - TipRanks.com

Vertex Pharmaceuticals Incorporated (VRTX) M&A Call Transcript

Vertex Pharmaceuticals Incorporated (VRTX) Crinetics Pharmaceuticals, Inc. - M&A Call - Slideshow (NASDAQ:VRTX) 2026-07-06